1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Nasty email from Brad

Discussion in 'Kowa Pharmaceuticals' started by anonymous, Aug 30, 2016 at 11:27 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Thats the tea pot calling the kettle black - loafers. You are an empty suit Brad.
     

  2. anonymous

    anonymous Guest

    Reps work hard and do well, exceed their goals.
    Then.....
    Goals go up dramatically and those same reps are now "loafers".

    Remember, the goals were pre-set for the year, obviously we pre-calculated you would exceed your goals by 30%.
     
  3. anonymous

    anonymous Guest

    Brad's message reminds me of the national conference call he had back when Livalo was out a couple of months and he was threatening us with our job if we didn't perform.
    C'mon Brad. We all want to do well.
     
  4. anonymous

    anonymous Guest

    Terrible email! The above post is right, you do really well 1 quarter so they put unrealistic goals for the rest.
    We are all working our best, trust us, we are tougher on ourselves than anyone else.
     
  5. anonymous

    anonymous Guest

    Goal based systems punish the performers and reward the weak.
     
  6. anonymous

    anonymous Guest

    Soooooo true! The reps who were on the bottom last year are now miraculously on top! Lol, what a joke. Wonder what IC plan we are in store for next year!
     
  7. anonymous

    anonymous Guest

     
  8. anonymous

    anonymous Guest

    Bye bye Brad!
     
  9. anonymous

    anonymous Guest

    And hello Jeff!
     
  10. anonymous

    anonymous Guest

    I miss Brad.